ATE376020T1 - Verfahren zu herstellung von aktivierten polyethylenglykolen - Google Patents
Verfahren zu herstellung von aktivierten polyethylenglykolenInfo
- Publication number
- ATE376020T1 ATE376020T1 AT02758000T AT02758000T ATE376020T1 AT E376020 T1 ATE376020 T1 AT E376020T1 AT 02758000 T AT02758000 T AT 02758000T AT 02758000 T AT02758000 T AT 02758000T AT E376020 T1 ATE376020 T1 AT E376020T1
- Authority
- AT
- Austria
- Prior art keywords
- polyethylene glycols
- activated polyethylene
- producing activated
- sup
- npc
- Prior art date
Links
- 229920001223 polyethylene glycol Polymers 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 239000012190 activator Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Polyethers (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31380101P | 2001-08-22 | 2001-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE376020T1 true ATE376020T1 (de) | 2007-11-15 |
Family
ID=23217202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02758000T ATE376020T1 (de) | 2001-08-22 | 2002-08-22 | Verfahren zu herstellung von aktivierten polyethylenglykolen |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7125558B2 (de) |
| EP (1) | EP1419191B1 (de) |
| AT (1) | ATE376020T1 (de) |
| CA (1) | CA2457876C (de) |
| DE (1) | DE60223047T2 (de) |
| WO (1) | WO2003018665A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2271233T3 (es) * | 2001-03-08 | 2007-04-16 | Bioartificial Gel Technologies Inc. | Hidrogel fijado a soporte y metodo para elaborar el mismo. |
| EP1419191B1 (de) | 2001-08-22 | 2007-10-17 | Bioartificial Gel Technologies Inc. | Verfahren zu herstellung von aktivierten polyethylenglykolen |
| WO2005037336A1 (en) * | 2003-10-21 | 2005-04-28 | Bioartificial Gel Technologies Inc. | Hydrogel-containing medical articles and methods of using and making the same |
| US7351787B2 (en) * | 2004-03-05 | 2008-04-01 | Bioartificial Gel Technologies, Inc. | Process for the preparation of activated polyethylene glycols |
| EP1865920A1 (de) * | 2005-04-04 | 2007-12-19 | Bioartificial Gel Technologies Inc. | Verhütung und behandlung von strahlenbedingter dermatitis |
| WO2006105665A1 (en) * | 2005-04-06 | 2006-10-12 | Bioartificial Gel Technologies Inc. | Hydrogel composition for modulation of topical inflammatory response |
| EP1973525B1 (de) * | 2005-12-05 | 2014-04-30 | RBA Pharma Inc. | Emulsionshaltige medizinische artikel |
| RU2441036C1 (ru) * | 2010-09-30 | 2012-01-27 | Общество с ограниченной ответственностью Научно-производственное объединение "Перспектива" (ООО НПО "Перспектива") | Способ получения активированного полиэтиленоксида |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3463862A (en) | 1964-05-21 | 1969-08-26 | Geneva Carol Mazza | Albumin containing comsmetic lotion |
| US4464468A (en) | 1968-03-29 | 1984-08-07 | Agence Nationale De Valorisation De La Recherche (Anvar) | Immobilization of active protein by cross-linking to inactive protein |
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| IL47468A (en) | 1975-06-12 | 1979-05-31 | Rehovot Res Prod | Process for the cross-linking of proteins using water soluble cross-linking agents |
| US4002531A (en) | 1976-01-22 | 1977-01-11 | Pierce Chemical Company | Modifying enzymes with polyethylene glycol and product produced thereby |
| CH625702A5 (de) | 1977-01-18 | 1981-10-15 | Delalande Sa | |
| US4264155A (en) | 1979-07-09 | 1981-04-28 | Opticol Corporation | Collagen contact lens |
| USRE33997E (en) | 1981-02-09 | 1992-07-14 | Allergan, Inc. | Biologically stabilized compositions comprising collagen as the minor component with ethylenically unsaturated compounds used as contact lenses |
| US4388428A (en) | 1981-07-20 | 1983-06-14 | National Patent Development Corporation | Biologically stabilized compositions comprising collagen as the major component with ethylenically unsaturated compounds used as contact lenses |
| FR2565160B1 (fr) | 1984-06-04 | 1987-03-06 | Essilor Int | Procede pour la realisation d'une lentille de contact souple en polymere(s) proteique(s) naturel(s), et lentille de contact ainsi obtenue |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US4752627A (en) | 1986-08-13 | 1988-06-21 | Michael Froix | Clouding-resistant contact lens compositions |
| US5114627A (en) | 1986-10-16 | 1992-05-19 | Cbs Lens | Method for producing a collagen hydrogel |
| US5051406A (en) | 1987-03-04 | 1991-09-24 | Nippon Hypox Laboratories Incorporated | Pharmaceutical composition using albumin as a carrier and process for producing the same |
| FR2617763B1 (fr) | 1987-07-07 | 1989-12-01 | Essilor Int | Procede de fabrication de lentille de contact en un polymere proteique naturel, par moulage avant reticulation |
| MX12394A (es) | 1987-07-23 | 1993-12-01 | Ciba Geigy Ag | Procedimiento par la obtencion de carbamatos de polietilenglicol. |
| US5214131A (en) | 1988-05-06 | 1993-05-25 | Sumitomo Pharmaceuticals Company, Limited | Polyethylene glycol derivatives, modified peptides and production thereof |
| US5324844A (en) | 1989-04-19 | 1994-06-28 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
| US5122614A (en) | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
| US5342940A (en) | 1989-05-27 | 1994-08-30 | Sumitomo Pharmaceuticals Company, Limited | Polyethylene glycol derivatives, process for preparing the same |
| US5286637A (en) | 1989-08-07 | 1994-02-15 | Debiopharm, S.A. | Biologically active drug polymer derivatives and method for preparing same |
| US5079018A (en) | 1989-08-14 | 1992-01-07 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
| US5039540A (en) | 1989-08-14 | 1991-08-13 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
| JP3051145B2 (ja) | 1990-08-28 | 2000-06-12 | 住友製薬株式会社 | 新規なポリエチレングリコール誘導体修飾ペプチド |
| US5545698A (en) | 1990-08-31 | 1996-08-13 | University Of Minnesota | Polyethylene glycol derivatives for solid-phase applications |
| US5235028A (en) | 1990-08-31 | 1993-08-10 | University Of Minnesota | Polyethylene glycol derivatives for solid-phase applications |
| US5229366A (en) | 1990-10-23 | 1993-07-20 | Fuji Photo Film Co., Ltd. | Peptide-containing polyethylene glycol derivatives and application thereof |
| US5252714A (en) | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
| US5595732A (en) | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
| US5281698A (en) | 1991-07-23 | 1994-01-25 | Cetus Oncology Corporation | Preparation of an activated polymer ester for protein conjugation |
| IT1260468B (it) | 1992-01-29 | 1996-04-09 | Metodo per mantenere l'attivita' di enzimi proteolitici modificati con polietilenglicole | |
| US5284974A (en) | 1992-08-11 | 1994-02-08 | Monsanto Company | Process for the preparation of thioacetamide |
| US5382657A (en) | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
| US5298643A (en) | 1992-12-22 | 1994-03-29 | Enzon, Inc. | Aryl imidate activated polyalkylene oxides |
| US5349001A (en) | 1993-01-19 | 1994-09-20 | Enzon, Inc. | Cyclic imide thione activated polyalkylene oxides |
| JP3351476B2 (ja) | 1993-01-22 | 2002-11-25 | 三菱化学株式会社 | リン脂質誘導体及びそれを含有するリポソーム |
| US5321095A (en) | 1993-02-02 | 1994-06-14 | Enzon, Inc. | Azlactone activated polyalkylene oxides |
| US5298410A (en) | 1993-02-25 | 1994-03-29 | Sterling Winthrop Inc. | Lyophilized formulation of polyethylene oxide modified proteins with increased shelf-life |
| US5605976A (en) | 1995-05-15 | 1997-02-25 | Enzon, Inc. | Method of preparing polyalkylene oxide carboxylic acids |
| US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| ATE215106T1 (de) | 1993-12-01 | 2002-04-15 | Bioartificial Gel Technologies Inc | Hydrogel auf basis von albumin |
| US5650234A (en) | 1994-09-09 | 1997-07-22 | Surface Engineering Technologies, Division Of Innerdyne, Inc. | Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| ES2185769T3 (es) | 1995-04-14 | 2003-05-01 | Kazunori Kataoka | Oxidos de polietileno con un resto sacarido en un extremo y un grupo funcional diferente en el otro extremo y procedimientos de produccion de los mismos. |
| US6214966B1 (en) | 1996-09-26 | 2001-04-10 | Shearwater Corporation | Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution |
| WO1999057155A1 (en) | 1998-05-01 | 1999-11-11 | The Procter & Gamble Company | Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein |
| DE19903655A1 (de) | 1999-01-29 | 2000-08-10 | Beiersdorf Ag | Proteinhaltige Hydrogele |
| US6348558B1 (en) * | 1999-12-10 | 2002-02-19 | Shearwater Corporation | Hydrolytically degradable polymers and hydrogels made therefrom |
| ATE337358T1 (de) | 2000-04-04 | 2006-09-15 | Bioartificial Gel Technologies Inc | Verfahren zur herstellung proteinhaltigen hydrogelen |
| ES2271233T3 (es) | 2001-03-08 | 2007-04-16 | Bioartificial Gel Technologies Inc. | Hidrogel fijado a soporte y metodo para elaborar el mismo. |
| US7615593B2 (en) * | 2001-04-23 | 2009-11-10 | Wisconsin Alumni Research Foundation | Bifunctional-modified hydrogels |
| EP1419191B1 (de) | 2001-08-22 | 2007-10-17 | Bioartificial Gel Technologies Inc. | Verfahren zu herstellung von aktivierten polyethylenglykolen |
-
2002
- 2002-08-22 EP EP02758000A patent/EP1419191B1/de not_active Expired - Lifetime
- 2002-08-22 CA CA2457876A patent/CA2457876C/en not_active Expired - Fee Related
- 2002-08-22 US US10/487,392 patent/US7125558B2/en not_active Expired - Lifetime
- 2002-08-22 DE DE60223047T patent/DE60223047T2/de not_active Expired - Lifetime
- 2002-08-22 WO PCT/CA2002/001306 patent/WO2003018665A1/en not_active Ceased
- 2002-08-22 AT AT02758000T patent/ATE376020T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60223047T2 (de) | 2008-07-24 |
| WO2003018665A1 (en) | 2003-03-06 |
| DE60223047D1 (de) | 2007-11-29 |
| US7125558B2 (en) | 2006-10-24 |
| EP1419191B1 (de) | 2007-10-17 |
| EP1419191A1 (de) | 2004-05-19 |
| CA2457876C (en) | 2011-10-11 |
| CA2457876A1 (en) | 2003-03-06 |
| US20050080206A1 (en) | 2005-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20041459L (no) | Kopolymerer for gelatinering av syrer | |
| ATE311363T1 (de) | Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren | |
| HUP0105077A2 (hu) | Szerin-proteáz inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
| WO1998014164A3 (de) | Verwendung wasserlöslicher copolymere als wirkstoffe in kosmetischen formulierungen | |
| DE60230127D1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
| ATE376020T1 (de) | Verfahren zu herstellung von aktivierten polyethylenglykolen | |
| DE69813565D1 (de) | Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung | |
| ATE537173T1 (de) | Verfahren zur herstellung von cucurbiturilen | |
| DE60113277T2 (de) | Verfahren zur herstellung von dicarbonsäurediarylestern | |
| ATE380173T1 (de) | Verfahren zur herstellung von (2s,3r,4s)-4- hydroxyisoleucin und analoga | |
| ATE251121T1 (de) | Verfahren zur herstellung von 1,3,6- hexantricarbonitril | |
| DE59404784D1 (de) | Neue carbonsäureester von 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren herstellung sowie deren verwendung | |
| ATE392413T1 (de) | Verfahren zur herstellung von beta-alaninamiden | |
| ATE267788T1 (de) | Verfahren zur wärmenutzung bei der herstellung von 1,2-dichlorethan | |
| ATE338026T1 (de) | 4-cyano-3-hydroxy-butanoyl hydrazine, derivate und verfahren zu ihrer herstellung | |
| DE50003633D1 (de) | Verfahren zur herstellung von l-ascorbinsäure | |
| DE60218774D1 (de) | Verfahren zur Herstellung von N,N-carbonyl diimidazol | |
| DK1194398T3 (da) | Syntese af (R)- og (S)-aminocarnitin og dets derivater med udgangspunkt i D- og L-asparginsyre | |
| ATE338747T1 (de) | Verfahren zur herstellung von aminopyrrolidinderivaten | |
| DE60014102D1 (de) | Verfahren zur herstellung von betainen | |
| DE60029245D1 (de) | Verfahren zur herstellung von aryltriazolinonen | |
| DE69410073D1 (de) | Verfahren zur Herstellung von 2-Perfluoroalkyl-3-oxazolin-5-one | |
| DE50214965D1 (de) | Reaktive azofarbstoffe, verfahren zu ihrer herstellung und ihre verwendung | |
| ATE231485T1 (de) | Verfahren zur herstellung von arylmalonaten | |
| DE59501234D1 (de) | Verfahren zur Herstellung von 2-Nitrobenzaldehyden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |